Review and clinical perspectives for the use of infliximab in ulcerative colitis

Infliximab is a chimeric, monoclonal anti-tumour necrosis factor-alpha antibody. It has been previously demonstrated to be an effective treatment for patients with Crohn’s disease who do not achieve the desired response with conventional treatments. Although the etiology of ulcerative colitis (UC) d...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Panaccione, Remo, Fedorak, Richard N, Aumais, Guy, Bernard, Edmond-Jean, Bernstein, Charles N, Bitton, Alain, Croitoru, Ken, Dieleman, Levinus A, Enns, Robert, Feagan, Brian G, Franchimont, Denis, Greenberg, Gordon R, Griffiths, Anne-Marie, Marshall, John K, Pare, Pierre, Patel, Sunil, Penner, Robert, Render, Craig, Seidman, Ernest, Steinhart, A Hillary
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Pulsus Group Inc 2008
Konular:
Review
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2662201/
https://ncbi.nlm.nih.gov/pubmed/18354755
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller